General News

Item 9 Labs Corp. Receives Approval to Operate

Newly Expanded Arizona Cultivation Facility to Begin Production This Week

PHOENIX, June 11, 2019 (GLOBE NEWSWIRE) — Item 9 Labs Corp. (OTC: INLB) (“Item 9 Labs” or the “Company”), a leader in comfortable cannabis health solutions for the modern consumer, today announced its expanded Arizona cultivation and manufacturing facility has received state approval to operate. The custom 10,000 square-foot construction passed inspections on June 4th and will begin production this week.

Several years of research and development went into analyzing the Company’s original cultivation site before expansion commenced in 2018. The new building features technology improvements in all areas of the grow process, including advanced irrigation, lighting, HVAC, and upgraded environmental controls.

“Our expanded Arizona facility will enable us to increase our cultivation and extraction production by approximately 150 percent, while maintaining a weekly harvest schedule,” stated Item 9 Labs CEO Sara Gullickson.

The Item 9 Labs Arizona facility now totals 20,000 square-feet consisting of 8 flower rooms, just over 1,000 square-feet of nursery space, an Extraction Laboratory, and an Infusion Kitchen for increased manufacturing capabilities.

“The completion of this project is a significant milestone for the organization,” commented COO Chris Wolven. “We were able to build our dream facility from the ground up, allowing us to expand on our award-winning quality products, grow our revenue, and onboard new talent.”

The improvements complete the second-phase of a three-tiered development initiative and continues Item 9 Labs’ strategic growth plan. The Company will hire approximately 20 new individuals to its operations force, as well as build its marketing, design, sales, and training teams.

Headquartered in Southern Arizona, Item 9 Labs is renowned for its award-winning flower, diverse concentrate products, and proprietary THC and CBD-derived delivery systems, including an Intra-Nasal device and Apollo Vape Pen and Pod System. The Company intends to manage cultivation, processing, distribution, and dispensary facilities in six to ten U.S. cannabis markets by the end of 2019.


To read the full article, click here by Neko Catanzaro.

Source: GlobeNewsWire via QuoteMedia